Cardiovascular Disease Development Expertise

Veristat is passionate about advancing breakthrough therapies that treat and manage cardiovascular disease, the leading killer of people today. Veristat is honored to have worked on over 75 cardiovascular studies!

Explore Our Recent Cardiovascular Disease Experience

  • Drugs to prevent and/or treat the following:
    • Acute Hereditary Angioedema Attacks
    • Blood Loss Prevention in Cardiac Surgery
    • Congenital Heart Disease
    • Coronary Arterial Restenosis
    • Coronary Artery Disease/CABG
    • Homozygous Familial Hypercholesterolemia (HoFH)
    • Vascular Injury
  • Devices such as stents and grafts
  • Diagnostics such as imaging for heart failure and deep vein thrombosis
CardioVascular.png

Contact Veristat To Learn More

veristat-therapeutic-expertise-cardiology.png

We will help you develop your breakthrough treatments to diagnose, treat or fix damage to the heart and vascular system for babies, children and adults.     Whether you are looking to repair congenital heart defects in babies, prevent cardiovascular disease onset due to genetic disorders in children and adolescents or prevent blood loss during cardiac bypass surgery, look to Veristat.

Our teams' will partner to guide you through the design and management of your clinical development project or program.   And, we’ll help you plan and navigate the regulatory submission process.    Contact us to learn more about our experiences and how we can apply our experience and knowledge to your study.

Contact Us

Stay up to Date with Veristat